Amarin | AMRN - Market Capitalization


Amarin reported $298.2M in Market Capitalization this August of 2026, considering the latest stock price and the number of outstanding shares.





Market Capitalization Change Date
AbbVie USD 435.86B 8.73B Aug/2026
Alnylam Pharmaceuticals USD 40.19B 3.96B Jun/2026
Amarin USD 290M 51M Dec/2025
AstraZeneca USD 178.16B 111.83B Aug/2026
BioCryst Pharmaceuticals USD 1.9B 643M Aug/2026
DBV Technologies USD 1.23B 327M Mar/2026
GlaxoSmithKline GBP 80.14B 3.66B Jun/2026
Halozyme Therapeutics USD 7.66B 257M Mar/2026
Heron Therapeutics USD 238M 7M Dec/2025
Ionis Pharmaceuticals USD 13.1B 642M Jun/2026
Nektar Therapeutics USD 12.98B 10.86B Aug/2026
Neurocrine Biosciences USD 16.95B 3.7B Jun/2026
Novartis USD 240.59B 67.17B Jun/2026